| 4.5 |
13.5 |
GO:0097402 |
neuroblast migration(GO:0097402) |
| 1.4 |
12.2 |
GO:0060613 |
fat pad development(GO:0060613) |
| 1.3 |
7.6 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 1.1 |
2.1 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 1.0 |
3.1 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.8 |
2.4 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.8 |
2.3 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.8 |
1.5 |
GO:0002182 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.7 |
4.5 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.7 |
1.5 |
GO:0003404 |
optic vesicle morphogenesis(GO:0003404) |
| 0.7 |
3.7 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.7 |
2.2 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.7 |
2.9 |
GO:1900145 |
regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.7 |
4.3 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.7 |
7.0 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.7 |
0.7 |
GO:1901630 |
negative regulation of presynaptic membrane organization(GO:1901630) |
| 0.7 |
0.7 |
GO:0032805 |
positive regulation of low-density lipoprotein particle receptor catabolic process(GO:0032805) |
| 0.6 |
1.8 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.6 |
1.8 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.6 |
0.6 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
| 0.6 |
3.9 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 0.6 |
1.1 |
GO:0072179 |
nephric duct formation(GO:0072179) |
| 0.5 |
2.2 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.5 |
1.6 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
| 0.5 |
5.1 |
GO:0060235 |
lens induction in camera-type eye(GO:0060235) |
| 0.5 |
2.5 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.5 |
2.0 |
GO:0072048 |
pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
| 0.5 |
4.9 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.5 |
1.9 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.5 |
0.5 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.5 |
3.7 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.5 |
2.3 |
GO:0060594 |
mammary gland specification(GO:0060594) |
| 0.4 |
1.6 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.4 |
1.1 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.4 |
0.7 |
GO:0030862 |
regulation of polarized epithelial cell differentiation(GO:0030860) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.4 |
5.0 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.3 |
1.0 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.3 |
1.0 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.3 |
0.7 |
GO:0060051 |
negative regulation of protein glycosylation(GO:0060051) |
| 0.3 |
1.0 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.3 |
1.3 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.3 |
2.0 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.3 |
3.3 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.3 |
1.3 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.3 |
0.3 |
GO:1902263 |
apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.3 |
2.5 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.3 |
1.2 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.3 |
1.8 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.3 |
1.2 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.3 |
0.3 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 0.3 |
0.9 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.3 |
0.9 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.3 |
2.9 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.3 |
1.2 |
GO:0042414 |
epinephrine metabolic process(GO:0042414) |
| 0.3 |
0.9 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.3 |
0.9 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
| 0.3 |
0.9 |
GO:0048352 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) |
| 0.3 |
0.8 |
GO:0010871 |
negative regulation of receptor biosynthetic process(GO:0010871) |
| 0.3 |
1.1 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.3 |
0.8 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 0.3 |
0.8 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.3 |
1.1 |
GO:0006447 |
regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
| 0.3 |
1.0 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 0.3 |
0.8 |
GO:0044413 |
evasion or tolerance of host defenses by virus(GO:0019049) positive regulation of transforming growth factor beta3 production(GO:0032916) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 0.3 |
0.8 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.3 |
0.8 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 0.3 |
0.8 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.3 |
0.8 |
GO:1903416 |
regulation of calcidiol 1-monooxygenase activity(GO:0060558) response to glycoside(GO:1903416) |
| 0.2 |
1.0 |
GO:0055009 |
extraocular skeletal muscle development(GO:0002074) atrial cardiac muscle tissue development(GO:0003228) pulmonary myocardium development(GO:0003350) subthalamus development(GO:0021539) subthalamic nucleus development(GO:0021763) atrial cardiac muscle tissue morphogenesis(GO:0055009) left lung morphogenesis(GO:0060460) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) |
| 0.2 |
0.7 |
GO:0051695 |
actin filament uncapping(GO:0051695) |
| 0.2 |
1.2 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.2 |
1.0 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.2 |
0.2 |
GO:0021557 |
oculomotor nerve development(GO:0021557) |
| 0.2 |
1.2 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.2 |
0.5 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 0.2 |
0.7 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 0.2 |
1.0 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.2 |
0.7 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.2 |
2.1 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.2 |
2.1 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.2 |
3.6 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.2 |
2.3 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.2 |
2.2 |
GO:0032252 |
secretory granule localization(GO:0032252) |
| 0.2 |
0.9 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.2 |
2.7 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.2 |
0.9 |
GO:0046878 |
regulation of saliva secretion(GO:0046877) positive regulation of saliva secretion(GO:0046878) positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.2 |
0.2 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 0.2 |
0.7 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.2 |
0.6 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) terpenoid catabolic process(GO:0016115) primary alcohol catabolic process(GO:0034310) |
| 0.2 |
1.3 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.2 |
0.6 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.2 |
0.6 |
GO:0045659 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.2 |
0.6 |
GO:0045014 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) detection of glucose(GO:0051594) |
| 0.2 |
1.5 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.2 |
0.2 |
GO:0090194 |
negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
| 0.2 |
1.5 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.2 |
1.9 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.2 |
0.4 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.2 |
0.8 |
GO:0061010 |
gall bladder development(GO:0061010) |
| 0.2 |
0.8 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.2 |
0.6 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.2 |
0.8 |
GO:1901492 |
positive regulation of lymphangiogenesis(GO:1901492) |
| 0.2 |
1.0 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.2 |
1.1 |
GO:0051660 |
cortical microtubule organization(GO:0043622) establishment of centrosome localization(GO:0051660) |
| 0.2 |
0.6 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.2 |
0.9 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 0.2 |
0.7 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.2 |
0.5 |
GO:0002339 |
B cell selection(GO:0002339) |
| 0.2 |
0.5 |
GO:0002331 |
pre-B cell allelic exclusion(GO:0002331) signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.2 |
1.3 |
GO:0002072 |
optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
| 0.2 |
0.4 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
| 0.2 |
0.9 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.2 |
0.5 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.2 |
0.7 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.2 |
0.5 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.2 |
0.7 |
GO:0046666 |
retinal cell programmed cell death(GO:0046666) |
| 0.2 |
1.9 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 |
0.3 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.2 |
1.5 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.2 |
0.7 |
GO:0043974 |
histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.2 |
0.3 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.2 |
1.0 |
GO:0098543 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.2 |
0.3 |
GO:2000224 |
testosterone biosynthetic process(GO:0061370) regulation of testosterone biosynthetic process(GO:2000224) |
| 0.2 |
1.0 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.2 |
1.2 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.2 |
0.7 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.2 |
0.5 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.2 |
1.3 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.2 |
0.5 |
GO:0048208 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.2 |
0.5 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.2 |
0.5 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.2 |
0.5 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.2 |
0.5 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
| 0.2 |
0.5 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.2 |
0.8 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.2 |
1.3 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.2 |
1.3 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 0.2 |
0.6 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.2 |
0.9 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.2 |
0.6 |
GO:1900107 |
regulation of nodal signaling pathway(GO:1900107) |
| 0.2 |
0.8 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.2 |
0.9 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.2 |
1.7 |
GO:0033523 |
histone H2B ubiquitination(GO:0033523) |
| 0.2 |
1.4 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.1 |
0.3 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.1 |
0.6 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.1 |
1.2 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.1 |
0.6 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.1 |
GO:0034392 |
negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
| 0.1 |
0.3 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
| 0.1 |
1.2 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.1 |
1.9 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.1 |
0.9 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.1 |
0.4 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.1 |
1.3 |
GO:0046499 |
S-adenosylmethioninamine metabolic process(GO:0046499) |
| 0.1 |
0.7 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.1 |
0.7 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.1 |
0.7 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.1 |
2.4 |
GO:0001709 |
cell fate determination(GO:0001709) |
| 0.1 |
0.1 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.1 |
4.5 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 |
0.6 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.1 |
0.3 |
GO:0090289 |
regulation of osteoclast proliferation(GO:0090289) |
| 0.1 |
0.4 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 |
1.2 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 |
0.7 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 |
0.4 |
GO:1904395 |
positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.1 |
0.4 |
GO:0040009 |
nucleolus to nucleoplasm transport(GO:0032066) regulation of growth rate(GO:0040009) |
| 0.1 |
1.7 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.1 |
0.4 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.1 |
0.4 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.1 |
0.7 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.1 |
0.9 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
1.0 |
GO:0010766 |
negative regulation of sodium ion transport(GO:0010766) |
| 0.1 |
0.5 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.1 |
0.6 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.1 |
1.3 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.1 |
1.9 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.1 |
0.3 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 0.1 |
1.1 |
GO:0032310 |
prostaglandin secretion(GO:0032310) |
| 0.1 |
0.9 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.1 |
0.3 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 |
0.7 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
0.4 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.1 |
0.2 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 |
1.6 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
1.1 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.1 |
0.2 |
GO:0035886 |
vascular smooth muscle cell differentiation(GO:0035886) |
| 0.1 |
0.2 |
GO:0071305 |
cellular response to vitamin D(GO:0071305) |
| 0.1 |
0.5 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.1 |
0.9 |
GO:0048570 |
notochord morphogenesis(GO:0048570) |
| 0.1 |
0.7 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 |
0.7 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
0.5 |
GO:2000484 |
positive regulation of interleukin-8 secretion(GO:2000484) |
| 0.1 |
0.7 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.1 |
0.6 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 0.1 |
0.3 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 |
0.3 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.1 |
0.3 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.1 |
0.6 |
GO:0071205 |
clustering of voltage-gated potassium channels(GO:0045163) protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.1 |
2.8 |
GO:0006940 |
regulation of smooth muscle contraction(GO:0006940) |
| 0.1 |
0.5 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.1 |
1.5 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.1 |
0.5 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.1 |
0.3 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.1 |
0.7 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.1 |
0.7 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.1 |
1.0 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
0.1 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.1 |
0.3 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.1 |
1.2 |
GO:0046643 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.1 |
0.4 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 |
0.3 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.1 |
0.2 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.1 |
0.9 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 |
0.4 |
GO:0051890 |
regulation of cardioblast differentiation(GO:0051890) transdifferentiation(GO:0060290) |
| 0.1 |
0.5 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.1 |
0.4 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.1 |
0.7 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
0.5 |
GO:0070779 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.1 |
0.3 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.1 |
0.4 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 |
0.4 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.1 |
0.4 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.1 |
0.4 |
GO:0065001 |
negative regulation of histone H3-K36 methylation(GO:0000415) specification of axis polarity(GO:0065001) |
| 0.1 |
0.4 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 |
0.6 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.1 |
0.4 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.1 |
0.5 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.1 |
0.9 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.1 |
0.3 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.1 |
0.2 |
GO:0001705 |
ectoderm formation(GO:0001705) |
| 0.1 |
0.9 |
GO:0036120 |
response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.1 |
0.3 |
GO:0046078 |
deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) dUMP metabolic process(GO:0046078) |
| 0.1 |
0.9 |
GO:0034312 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.1 |
0.8 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.1 |
1.4 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.1 |
0.5 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.1 |
0.5 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.1 |
1.0 |
GO:0031498 |
nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
| 0.1 |
0.6 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.1 |
0.1 |
GO:0030859 |
polarized epithelial cell differentiation(GO:0030859) |
| 0.1 |
0.8 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 |
0.3 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.1 |
0.3 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.1 |
0.8 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.1 |
0.2 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.1 |
1.7 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.1 |
0.4 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.1 |
0.3 |
GO:1900149 |
positive regulation of Schwann cell migration(GO:1900149) |
| 0.1 |
0.2 |
GO:0045410 |
positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.1 |
1.0 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.1 |
0.2 |
GO:1903960 |
negative regulation of anion transmembrane transport(GO:1903960) |
| 0.1 |
0.3 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.1 |
0.4 |
GO:0042711 |
maternal behavior(GO:0042711) |
| 0.1 |
0.9 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.1 |
0.1 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.1 |
0.5 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.1 |
0.7 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.1 |
0.7 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.1 |
0.2 |
GO:0030421 |
defecation(GO:0030421) |
| 0.1 |
0.7 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 |
0.3 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.1 |
0.9 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.1 |
0.9 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 |
0.6 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.1 |
0.2 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.1 |
0.2 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.1 |
0.3 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.1 |
0.4 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.1 |
0.3 |
GO:0033136 |
serine phosphorylation of STAT3 protein(GO:0033136) |
| 0.1 |
0.2 |
GO:0034141 |
positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.1 |
0.2 |
GO:0051220 |
cytoplasmic sequestering of protein(GO:0051220) |
| 0.1 |
0.2 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.1 |
0.5 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.1 |
0.4 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.1 |
0.2 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 |
1.1 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 |
0.4 |
GO:0032298 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 0.1 |
1.0 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.1 |
0.4 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
0.4 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 |
0.4 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.1 |
0.4 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 |
0.8 |
GO:0030828 |
positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 |
1.0 |
GO:0032875 |
regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
| 0.1 |
0.3 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 |
0.1 |
GO:0070571 |
negative regulation of neuron projection regeneration(GO:0070571) |
| 0.1 |
0.4 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.1 |
0.1 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.1 |
0.8 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.1 |
0.3 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 |
0.3 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.1 |
0.7 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.1 |
1.7 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.1 |
0.6 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.1 |
0.5 |
GO:0014009 |
glial cell proliferation(GO:0014009) |
| 0.1 |
0.2 |
GO:0019659 |
glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.1 |
0.5 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
1.9 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.1 |
0.3 |
GO:0060295 |
regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.1 |
0.3 |
GO:1900225 |
NLRP3 inflammasome complex assembly(GO:0044546) regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
| 0.1 |
0.5 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
0.3 |
GO:1900169 |
regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.1 |
0.3 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.1 |
0.2 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.1 |
0.2 |
GO:0019405 |
alditol catabolic process(GO:0019405) glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 |
0.2 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.1 |
0.7 |
GO:0010715 |
regulation of extracellular matrix disassembly(GO:0010715) |
| 0.1 |
0.3 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.1 |
0.1 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.1 |
0.2 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 |
0.2 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.1 |
0.2 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.1 |
0.4 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 |
2.1 |
GO:0007492 |
endoderm development(GO:0007492) |
| 0.1 |
0.2 |
GO:2000002 |
negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.1 |
0.4 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.1 |
1.1 |
GO:0045932 |
negative regulation of muscle contraction(GO:0045932) |
| 0.1 |
1.0 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.1 |
0.1 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 |
0.4 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
0.8 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 |
0.4 |
GO:0034969 |
histone arginine methylation(GO:0034969) |
| 0.1 |
0.3 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 |
0.3 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.1 |
1.1 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.1 |
0.6 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 |
0.2 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.1 |
0.3 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.1 |
0.2 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.1 |
0.6 |
GO:0040036 |
regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
| 0.1 |
0.3 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 |
0.1 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.1 |
0.1 |
GO:0044849 |
estrous cycle(GO:0044849) |
| 0.1 |
0.4 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
0.5 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 0.1 |
0.3 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.1 |
0.4 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.1 |
0.6 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.1 |
0.7 |
GO:0090224 |
regulation of spindle organization(GO:0090224) |
| 0.1 |
0.8 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.1 |
0.2 |
GO:0010825 |
positive regulation of centrosome duplication(GO:0010825) |
| 0.1 |
0.2 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.1 |
0.6 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.1 |
0.2 |
GO:0010744 |
positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
| 0.1 |
0.4 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.1 |
0.1 |
GO:1902566 |
regulation of eosinophil activation(GO:1902566) |
| 0.1 |
0.6 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.1 |
0.2 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.1 |
0.3 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.1 |
1.0 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.1 |
0.3 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.0 |
1.4 |
GO:0048255 |
mRNA stabilization(GO:0048255) |
| 0.0 |
0.1 |
GO:0048162 |
preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.0 |
0.4 |
GO:0001773 |
myeloid dendritic cell activation(GO:0001773) myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 |
0.3 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.0 |
1.3 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.0 |
1.0 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.0 |
0.2 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.0 |
0.7 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.0 |
0.3 |
GO:0070633 |
transepithelial transport(GO:0070633) |
| 0.0 |
0.5 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.0 |
0.2 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.0 |
0.3 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.0 |
0.6 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 |
0.5 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.0 |
0.7 |
GO:1900087 |
positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.0 |
1.0 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.0 |
GO:0046684 |
response to insecticide(GO:0017085) response to pyrethroid(GO:0046684) |
| 0.0 |
0.2 |
GO:0045652 |
regulation of megakaryocyte differentiation(GO:0045652) |
| 0.0 |
0.9 |
GO:0031065 |
positive regulation of histone deacetylation(GO:0031065) |
| 0.0 |
0.1 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.0 |
0.1 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 0.0 |
0.2 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.2 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.0 |
0.1 |
GO:0090148 |
protein hexamerization(GO:0034214) membrane fission(GO:0090148) |
| 0.0 |
0.7 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 |
0.6 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.0 |
0.5 |
GO:0001779 |
natural killer cell differentiation(GO:0001779) |
| 0.0 |
0.1 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.6 |
GO:0034377 |
plasma lipoprotein particle assembly(GO:0034377) |
| 0.0 |
0.2 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.0 |
0.1 |
GO:1904995 |
negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.0 |
0.3 |
GO:0015781 |
nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.0 |
0.2 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.0 |
0.5 |
GO:0055090 |
acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.0 |
0.5 |
GO:1902895 |
positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.0 |
1.1 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 |
0.7 |
GO:0086016 |
AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
| 0.0 |
0.6 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.0 |
0.2 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.0 |
0.2 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.0 |
0.2 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.0 |
0.1 |
GO:0010872 |
regulation of cholesterol esterification(GO:0010872) |
| 0.0 |
0.1 |
GO:1903984 |
regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.0 |
0.3 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.0 |
1.2 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.0 |
0.1 |
GO:0014042 |
positive regulation of neuron maturation(GO:0014042) |
| 0.0 |
0.3 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.0 |
0.3 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.0 |
0.2 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.0 |
0.1 |
GO:2001185 |
regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.0 |
0.1 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.0 |
0.3 |
GO:0046460 |
triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.0 |
0.4 |
GO:0008209 |
androgen metabolic process(GO:0008209) |
| 0.0 |
0.5 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 |
0.3 |
GO:0014841 |
skeletal muscle satellite cell proliferation(GO:0014841) skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
| 0.0 |
0.1 |
GO:0045104 |
intermediate filament cytoskeleton organization(GO:0045104) |
| 0.0 |
0.8 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
2.8 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.0 |
0.2 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.0 |
0.1 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.0 |
0.2 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.0 |
0.1 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.0 |
0.2 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.0 |
0.1 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.0 |
0.1 |
GO:0045112 |
integrin biosynthetic process(GO:0045112) |
| 0.0 |
0.2 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.0 |
1.5 |
GO:0002224 |
toll-like receptor signaling pathway(GO:0002224) |
| 0.0 |
0.8 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.0 |
0.1 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.0 |
0.2 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.0 |
0.1 |
GO:0001828 |
inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 0.0 |
0.2 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.0 |
0.3 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 |
0.2 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.0 |
0.1 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.0 |
0.2 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
| 0.0 |
0.2 |
GO:2000637 |
positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.0 |
1.2 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.0 |
0.3 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.0 |
0.3 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.0 |
0.1 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.0 |
0.2 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 |
0.3 |
GO:0002031 |
G-protein coupled receptor internalization(GO:0002031) |
| 0.0 |
0.1 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.0 |
0.3 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.0 |
0.1 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
0.2 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.0 |
0.7 |
GO:0001756 |
somitogenesis(GO:0001756) |
| 0.0 |
0.4 |
GO:0032516 |
positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.0 |
0.1 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 |
0.5 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.3 |
GO:0061339 |
establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.0 |
0.5 |
GO:0097009 |
energy homeostasis(GO:0097009) |
| 0.0 |
0.2 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.0 |
0.9 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.0 |
0.2 |
GO:1903069 |
regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 0.0 |
0.0 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.0 |
0.6 |
GO:0009409 |
response to cold(GO:0009409) |
| 0.0 |
0.4 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.0 |
0.6 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 |
0.0 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.0 |
0.1 |
GO:0035553 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.0 |
0.4 |
GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
| 0.0 |
0.3 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.2 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.6 |
GO:0051443 |
positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.0 |
0.4 |
GO:0003016 |
respiratory system process(GO:0003016) |
| 0.0 |
0.3 |
GO:0050858 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
| 0.0 |
0.1 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.0 |
0.2 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.0 |
0.1 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.0 |
0.1 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.0 |
0.2 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.0 |
0.2 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.0 |
0.1 |
GO:0055098 |
response to low-density lipoprotein particle(GO:0055098) |
| 0.0 |
0.4 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 |
0.1 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.0 |
0.1 |
GO:0086013 |
membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
| 0.0 |
0.3 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
0.0 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.0 |
0.4 |
GO:0010951 |
negative regulation of endopeptidase activity(GO:0010951) |
| 0.0 |
0.5 |
GO:0002088 |
lens development in camera-type eye(GO:0002088) |
| 0.0 |
0.2 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.0 |
0.2 |
GO:0034315 |
regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.0 |
0.1 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.0 |
0.3 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.0 |
0.2 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.0 |
0.2 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 |
0.1 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.0 |
GO:0033292 |
T-tubule organization(GO:0033292) |
| 0.0 |
0.2 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.0 |
0.3 |
GO:0009299 |
mRNA transcription(GO:0009299) |
| 0.0 |
0.1 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 |
0.1 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 |
0.1 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.0 |
0.1 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.0 |
0.3 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.0 |
0.1 |
GO:0045072 |
interferon-gamma biosynthetic process(GO:0042095) regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.0 |
0.2 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.0 |
0.1 |
GO:0045852 |
lysosomal lumen pH elevation(GO:0035752) pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.0 |
0.1 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.0 |
0.8 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
0.5 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
0.1 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 0.0 |
1.0 |
GO:0051304 |
chromosome separation(GO:0051304) |
| 0.0 |
0.3 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.0 |
0.3 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.0 |
0.1 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen(GO:0002478) antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.0 |
0.2 |
GO:0043267 |
negative regulation of potassium ion transport(GO:0043267) |
| 0.0 |
0.2 |
GO:0045740 |
positive regulation of DNA replication(GO:0045740) |
| 0.0 |
0.1 |
GO:0031440 |
regulation of mRNA 3'-end processing(GO:0031440) |
| 0.0 |
0.4 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
0.6 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.0 |
0.1 |
GO:0003094 |
glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
| 0.0 |
0.3 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
| 0.0 |
0.1 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.0 |
0.0 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.0 |
0.1 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.0 |
0.5 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.0 |
0.1 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.0 |
0.1 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.0 |
0.3 |
GO:0048662 |
negative regulation of smooth muscle cell proliferation(GO:0048662) |
| 0.0 |
0.1 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
0.1 |
GO:0001946 |
lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
| 0.0 |
0.1 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.0 |
0.1 |
GO:0006544 |
glycine metabolic process(GO:0006544) |
| 0.0 |
0.0 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.0 |
0.4 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.0 |
0.4 |
GO:0032611 |
interleukin-1 beta production(GO:0032611) |
| 0.0 |
0.2 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.0 |
0.0 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.0 |
0.1 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.0 |
0.8 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
0.0 |
GO:2001267 |
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
| 0.0 |
0.2 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.0 |
0.1 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.0 |
0.2 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.0 |
0.1 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 |
0.7 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.1 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.0 |
0.1 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.0 |
0.3 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.1 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.0 |
0.1 |
GO:0045446 |
endothelial cell differentiation(GO:0045446) |
| 0.0 |
0.0 |
GO:1903181 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 0.0 |
0.0 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.0 |
0.3 |
GO:0001974 |
blood vessel remodeling(GO:0001974) |
| 0.0 |
0.7 |
GO:0050679 |
positive regulation of epithelial cell proliferation(GO:0050679) |
| 0.0 |
0.0 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 |
0.1 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 |
0.1 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.0 |
0.1 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.0 |
0.2 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.0 |
0.0 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.0 |
0.0 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.0 |
0.2 |
GO:0034629 |
cellular protein complex localization(GO:0034629) |
| 0.0 |
0.1 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 |
0.2 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.0 |
0.5 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.0 |
0.2 |
GO:0007368 |
determination of left/right symmetry(GO:0007368) |
| 0.0 |
0.1 |
GO:0007143 |
female meiotic division(GO:0007143) |
